Clinical Trials
3
Active:1
Completed:1
Trial Phases
2 Phases
Phase 1:1
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (66.7%)Phase 1
1 (33.3%)Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
Not Applicable
Recruiting
- Conditions
- Spine DeformityScoliosisSpinal Muscular Atrophy
- First Posted Date
- 2023-05-19
- Last Posted Date
- 2025-08-08
- Lead Sponsor
- Alcyone Therapeutics, Inc
- Target Recruit Count
- 90
- Registration Number
- NCT05866419
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
🇵🇱Specialised Hospital Ludwika Rydygiera, Krakow, Poland
🇵🇱Research Institute of Polish Mother's Memorial Hospital, Łódź, Poland
Gene Therapy for Children With CLN3 Batten Disease
Phase 1
Active, not recruiting
- Conditions
- CLN3Batten Disease
- First Posted Date
- 2018-12-10
- Last Posted Date
- 2025-08-07
- Lead Sponsor
- Alcyone Therapeutics, Inc
- Target Recruit Count
- 7
- Registration Number
- NCT03770572
- Locations
- 🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States
Quantitative Characterization of Safe Irrigation for Ventricular Shunt Catheters
Not Applicable
Completed
- Conditions
- Hydrocephaly
- First Posted Date
- 2016-01-11
- Last Posted Date
- 2020-09-21
- Lead Sponsor
- Alcyone Therapeutics, Inc
- Target Recruit Count
- 4
- Registration Number
- NCT02651337
- Locations
- 🇺🇸
Boston Children's Hospital, Boston, Massachusetts, United States
News
No news found